ASHPOfficial

Opioid analgesic therapy is a common treatment for severe pain in the palliative care population.  As the population ages, more patients with a history of opioid misuse are experiencing chronic, severe, difficult to treat pain, often related to cancer.  This session will review various pain therapies for severe pain in the palliative care population and outline strategies for pain management in patients with comorbid use disorders. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

During this episode of ASHP’s Informatics Bytes podcast, we will describe the current state of autoverification, including the reasons and benefits of implementation. The speakers will also be discussing available tools and challenges that should be addressed when considering implementation.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this dynamic presentation from the 2021 Midyear Clinical Meeting, our content matter experts review the barriers and challenges under-represented minorities face as student pharmacists, pharmacists and pharmacy technicians, describe the value and impact of mentorship, and provide strategies that pharmacists, technicians and departments can implement to cultivate diversity, inclusion and equity within pharmacy practice settings.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast will address opportunities to develop relationships with payers to optimize patient outcomes.  With the expansion of ambulatory care populations health initiatives and prescription-based services, strategic relationships between pharmacy enterprise and payers has become increasingly important.     

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pursuing a residency specializing in pharmacy informatics is emerging as a popular route to begin a career as an informatics pharmacist. Hear from three current PGY2 Pharmacy Informatics Residents about their career path, residency experience, and hopes for training future informatics pharmacists.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Incorporation of Diversity, Equity, and Inclusion is important now more than ever. In this podcast, listeners will hear from a DEI expert relay his/her experiences of DEI in pharmacy practice and share his/ her knowledge to how to best approach DEI in local chapters.     

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the 2021 Midyear Clinical Meeting, our content matter experts will provide listeners with resources available with medication access for underserved patient populations, outline the provider role in improving care for these patients and design preliminary initiatives for enhanced medication access within your practice setting. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are currently in high impact roles within their organizations.  Discussion will involve their career paths, current or past activities they most enjoyed, advice for fellow informaticists, and where they envision informatics in the future. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode highlights the key take aways from the ASHP Section of Clinical Specialists and Scientists’ 2021 Midyear Clinical Meeting presentation on how pharmacists can help to counteract health misinformation with patients.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

While the utilization of topical hemostatic agents in the emergency department (ED) is dwarfed by its use in OR, ED pharmacists should have a basic understanding of these agents based on the critically ill and surgical patients that can reside in the ED. This podcast will evaluate the available topical hemostatic agents and their place in practice, specifically from the emergency department perspective.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.